Clinical Trial Update: Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes ongoing Phase 2/Phase 3 evaluation of post-transplant cyclophosphamide to prevent graft-versus-host disease in matched unre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Bone Marrow Transplant Complications, Graft Versus Host Disease | Phase 2, Phase 3 | Status: RECRUITING